Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Mishima

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
Annals of Hematology|September 12, 2025
Impact of best response to ibrutinib plus Bendamustine and rituximab on PFS in MCL: a secondary analysis of SHINEYuko Mishima, Daigo Hashimoto, Michiko Ichii, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|March 27, 2024
Complex karyotype determined using conventional cytogenetic analysis is a poor prognostic factor in patients with multiple myelomaHideki Uryu, Yuko Mishima, Yuko Ishihara, et al.
Hematological Oncology|July 12, 2017
Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutationNaoko Tsuyama, Reimi Asaka, Akito Dobashi, et al.
Leukemia & Lymphoma|November 9, 2007
Rituximab plus CHOP as an initial chemotherapy for patients with disseminated MALT lymphomaDaisuke Ennishi, Masahiro Yokoyama, Yuko Mishima, et al.
Cancer Science|February 8, 2007
MEK-ERK is involved in SUMO-1 foci formation on apoptosisRyoko Utsubo-Kuniyoshi, Yasuhito Terui, Yuko Mishima, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 29, 2017
Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in JapanMasahiro Yokoyama, Yoshiharu Kusano, Anna Takahashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 14, 2011
[Preventive effect of polaprezinc suspension dispersed in sodium alginate solution (P-AG) for stomatitis induced by Docetaxel/Cisplatin/Fluorouracil (DCF) chemotherapy in patients with head and neck cancer]Takahito Sugisaki, Kazuyoshi Kawakami, Maki Nemoto, et al.
International Journal of Hematology|January 16, 2020
Insignificance of surveillance imaging in patients with diffuse large B-cell lymphoma who achieved first complete remission: a retrospective cohort studyTakanori Fukuta, Noriko Nishimura, Yuko Shirouchi, et al.
Coronary Artery Disease|January 23, 2014
TNF-α production in NKT cell hybridoma is regulated by sphingosine-1-phosphate: implications for inflammation in atherosclerosisShiori Ito, Soichiro Iwaki, Rie Kondo, et al.
Journal of Thrombosis and Haemostasis : JTH|February 8, 2025
Andexanet-induced heparin resistance in cardiac surgery-a rapid review of case reports and seriesYuko Mishima, Grace Townsend, Shari C Clifton, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Annals of Hematology|September 12, 2025
Impact of best response to ibrutinib plus Bendamustine and rituximab on PFS in MCL: a secondary analysis of SHINEYuko Mishima, Daigo Hashimoto, Michiko Ichii, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|March 27, 2024
Complex karyotype determined using conventional cytogenetic analysis is a poor prognostic factor in patients with multiple myelomaHideki Uryu, Yuko Mishima, Yuko Ishihara, et al.
Hematological Oncology|July 12, 2017
Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutationNaoko Tsuyama, Reimi Asaka, Akito Dobashi, et al.
Leukemia & Lymphoma|November 9, 2007
Rituximab plus CHOP as an initial chemotherapy for patients with disseminated MALT lymphomaDaisuke Ennishi, Masahiro Yokoyama, Yuko Mishima, et al.
Cancer Science|February 8, 2007
MEK-ERK is involved in SUMO-1 foci formation on apoptosisRyoko Utsubo-Kuniyoshi, Yasuhito Terui, Yuko Mishima, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 29, 2017
Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in JapanMasahiro Yokoyama, Yoshiharu Kusano, Anna Takahashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 14, 2011
[Preventive effect of polaprezinc suspension dispersed in sodium alginate solution (P-AG) for stomatitis induced by Docetaxel/Cisplatin/Fluorouracil (DCF) chemotherapy in patients with head and neck cancer]Takahito Sugisaki, Kazuyoshi Kawakami, Maki Nemoto, et al.
International Journal of Hematology|January 16, 2020
Insignificance of surveillance imaging in patients with diffuse large B-cell lymphoma who achieved first complete remission: a retrospective cohort studyTakanori Fukuta, Noriko Nishimura, Yuko Shirouchi, et al.
Coronary Artery Disease|January 23, 2014
TNF-α production in NKT cell hybridoma is regulated by sphingosine-1-phosphate: implications for inflammation in atherosclerosisShiori Ito, Soichiro Iwaki, Rie Kondo, et al.
Journal of Thrombosis and Haemostasis : JTH|February 8, 2025
Andexanet-induced heparin resistance in cardiac surgery-a rapid review of case reports and seriesYuko Mishima, Grace Townsend, Shari C Clifton, et al.
Pageof 11